1) Tamaki N, Ohtani H, Yamashita K. et al : Metabolic activity in the areas of new fill-in after thallium-201 reinjection : Comparison with positron emission tomography using fluorine-18-deoxyglueose. J Nucl Med 32 : 673-678, 1991
3) DePucy EG : Myocardial perfusion imaging with thallium-201 to evaluate patients before and after percutaneous transluminal coronary angioplasty. Circulation 84 (suppl) : 159-165, 1991
2) Ono Y, Kamiya T, Kohata T, et al : Ischemic symptpoms in patients after Kawasaki disease, in Proceedings of the Forth intermnational symposium on Kawasaki disease (Ed, Takahasi M, Taubert K), pp.356-362, America Heart Association, 1993
2) Mitomori T, Ono, Y Kohata T, et al : Noninvasive evaluation of right ventricular pressure in children with heart disease : Quantitative assessment by thallium myocardial imaging (in Japanese). J Cardiography 16 : 993, 1986
3) Ono Y, Mitomori T, Fujino N, et al : Myocardial damage in patients with cyanotic heart disease assessed by Tallium-201 myocardial imaging. Pediatric Cardiology. p.195, Springer-Verlag Co, 1985
1) Li QS, et al : Technetium-99m methoxyisobutyl isonitrile (RP30) for quantification of rnyocardial ischemia and reperfusion in dogs. J Nucl Med 29 : 1539-1548, 1988
4) Gal RA, et al : Left ventricular volume calculation using a count-based ratio method applied to first-pass radionuclide angiography. J Nucl Med 33 : 2124-2132, 1992
2) Tamaki N, Kawamoto M, Yonekura Y, et al : Decreased uptake of BMIPP as a sign of enhanced glucose utilization assessed by FDG PET, J Nuc Med 32 : 1034 (abstract), 1991
1) Franken PR, Geeter FD. Dendale P, et al : Abnormal fatty acid uptake in subacute myocardial infarction after coronary thrombolysis : Correlation with wall motion and inotropic reserve J Nuc Med 35 : 1758-1765, 1994
P.128 掲載の参考文献
1) Kalff V, Schwalger M, Nguyen N, et al : The relationship between myocardial blood flow and glucose uptake tn ischemic canine myocadium determined with FDG. J Nucl Med 33 : 1346-1353, 1992
3) Tamaki N, Kawamoto M. Yonekura Y, et al : Decreat ed uptake of BMIPP as a sign of enhanced glucose utilization assessed by FDG PET. J Nuc Med 32 : 1034 (abstract), 1991
2) Tamaki N, Kawamoto M, Yonekura, et al : Regional metabolic abnormality in relation to perfusion and wall motton inpatients with myocardial infarction : assessment with emission tomography using iodonated branched fatty acid analogue. J Nucl Med 33 : 659-667, 1992
3) Shimonagata T, Nanto S, Ohara T, et al : Is free fatty acid metabolism impaired ln hibernating myocardium? J Nucl Med 35 (5) : 136 (abstract), 1994
2) Rahimtoola SH : A perspective on three largc multicenter randomized clinical trials or coronary bypass for stable angina Circulation 72 (suppl V) : V123-125, 1985
3) Shimonagata T, Nanto S. Ohara T, et al : Is free fatty acid metabolism impaired in hibernating myocardium? J Nucl Med 35 (5) : 136. 1994 (abstract)
4) Philippe RF, Frank De G, Paul D, et al : Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis : Correlation with wall motion and inotoropic reserve. J Nucl Med 35 : 1758-1765, 1994
P.140 掲載の参考文献
1) Nishimura T : Approaches to identify and characterize hypertrophic myocardium J Nucl Med 34 : 1013-1019. 1993
2) Kurata C, Kobayashi A, Yamazaki N : Dual tracer autoradiographic study with thallium-201 and radioiodinated fatty acid in cardiomyopathic hamsters. J Nucl Med 30 : 80-87 1989
1) Sisson JC. Shapiro B, Meyers L, et al : Metaiodobenzylguanidine to map scintigraphically the adrenaergic nervous system in man J Nucl Med 28 : 1625-1636, 1987
1) Schwaiger M. Guibourg H, Rosenspire K, et al : Effect of regional myocardial ischemia on sympathetic nerve system as assessed by fluorine-18-metaraminol. J Nuc Med 31 : 1352-1357, 1990
1) Handerson EB, Kahn JK, Corbett JR, et al : Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergie derangement in patients with congestive cardiomyopathy. Circulation 78 : 1192-1199, 1988
2) Merlet P. Delforg J, Dubois JL, et al : In vivo evaluation of mechanisms of down regulation in idiopathic cardio-myopathy using positron emission tomography (PET) with C-11 CGP 12177 and MIBG omaging : J Nucl Med 33 : 896, 1992
P.188 掲載の参考文献
1) Waagsten F, Hjalmarson A, Varnauskas E, et al : Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 37 : 1022-1036, 1975
3) Merlet P, Delforge J, Dubois JL, et al : In vivo evaluation of mechanisms of down regulation in idiopathic cardio-myopathy using positron emission tomography (PET) with C-11 CGP 12177 and MIBG imaging. J Nucl Med 33 : 896, 1922
1) Wakasugi S, Fischman AJ, Babich JW, et al : Metaiodobenzylguanidine : Evaluation of its potential as a tracer for monitoring doxorubicin cardiomyopathy. J Nucl Med 34 : 1282-1286, 1993
3) Rabinovitch MA, Rose CP, Schwab AJ, et al : A method of dynamic analysis of Iodine-123-metaiodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure J Nucl Med 34 : 589-600, 1993
1) Merlet P, Vallette H, Dubois-Rande J, et al : Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 33 : 471-477. 1992
3) Rabinovitch MA, Rose CP, Schwab AJ, et al : A method of dynamic analysis of lodine-123-metaiodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure. J Nucl Med 34 : 589-600, 1993
3) Simonds M, Isner JM : Assessment of relative sensitiveties of noninvasive tests for cardiac amyloidosis in documented cardiac amyloidosis. Am J Cardiol 69 : 425-427, 1992
3) Tamaki N, Yamada T, Matsumori A, et al : Indium-111-antimyosin antibody imaging for detecting different stages of myocardial infarction : Comparison with technetium-99m-pyrophosphate imaging. J Nucl Med 31 : 136-42, 1990
5) Nishimura T, Nagata S, Uehara T, et al : Assessment of myocardial damage in dilated-phase hypertrophic cardiomyopathy by using indium-111-antlmyosin Fab myocardial scintigraphy. J Nucl Med 32 : 1333-7, 1991
6) Nakata T, Gotoh M, Yonekura S, et a1 : Myocardial accumulation of monoclonal antlmyosin Fab ln hypertrophlc cardiomyopathy and postpartum cardiomyopathy. J Nucl Med 32 : 2291-4, 1991
4) Carrio I, Berna I., Ballester M, et al : Indium- 111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. J Nucl Med 29 : 1893-1900, 1988
2) Kubota R, Yamada S, Kubota K, et al : Intramural distribution of fluorine-18-fluorodeoxyglucose in vivo : Accumulation on macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33 : 1972-1980, 1992
2) Nienabar CA, Gambhir SS, et al : Regional myocardial blood flow and glucose utilization in symptomatic patients with hypertrophic cardiomyopathy. Circulation 87 : 1580-1590, 1993